These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4567004)

  • 1. [Treatment with antidysenteric Shigella flexneri vaccine].
    Tudor V; Dogaru D; Meitert T; Istrati G; Ciufecu C; Filip I
    Microbiol Parazitol Epidemiol (Bucur); 1972; 17(5):425-30. PubMed ID: 4567004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic bacillary dysentery using a live anti-dysentery vaccine].
    Istrati G; Meitert T; Ciufercu C; Sulea IT; Baron E; Jipa G; Popescu P; Eduard H; Antonescu O; Frunzetti L; Dobrescu A; Sulutiu E; Ionescu L; Tilica D; Ghisoiu V; Brinzac V; Ceauşescu I; Bădescu M
    Arch Roum Pathol Exp Microbiol; 1973 Mar; 32(1):22-33. PubMed ID: 4585402
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of dysentery bacilli carriers with a live nonpathogenic antidysenteric vaccine.
    Istrati G; Meitert T; Ciufeco C
    Arch Immunol Ther Exp (Warsz); 1968; 16(2):333-7. PubMed ID: 5664133
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of live Flexner 2a 516M dysentery vaccine for the immunotherapy of acute and chronic dysentery].
    Sultanov GV; Belaia IuA; Sadovskaia TA; Osmanova MM; Gadzhieva GR
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):33-8. PubMed ID: 7036601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati).
    Meitert T; Pencu E; Ciudin L; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):251-78. PubMed ID: 6400299
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of dysentery infections in human collectivities by means of polyvalent bacteriophages S. flexneri and S. sonnei].
    Kostrzewski J; Mulczyk M; Slopek S
    Przegl Epidemiol; 1974; 28(4):483-507. PubMed ID: 4614332
    [No Abstract]   [Full Text] [Related]  

  • 7. [Toxic megacolon due to Shigella: a report of a new case].
    Bolzan HE; Spatola J; Telleria F
    Acta Gastroenterol Latinoam; 1992; 22(4):243-6. PubMed ID: 1340679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shigellosis studies; resistance of Shigella flexneri III to therapy with sulfadiazine.
    WHITE BV; THOMPSON CM
    U S Nav Med Bull; 1946 May; 46():704-8. PubMed ID: 21022905
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficiency of immunoprophylaxis and immunotherapy by live dysentery vaccine administration in children and adults collectivities.
    Meitert T; Ciudin L; Pencu E; Tonciu M; Gheorghe G
    Arch Roum Pathol Exp Microbiol; 1982; 41(4):357-69. PubMed ID: 6763515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Shigella flexneri diarrhoea with positive blood culture].
    Taieb B; Ghnassia JC; Berche P; Hennequet A
    Ann Pediatr (Paris); 1978; 25(5-6):266-8. PubMed ID: 16114334
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoprophylaxis against bacillary dysentery by dysentery live vaccine Vadizen (Shigella flexneri T32-Istrati) in children collectivities in SV County.
    Bogus L; Ianopol L; Dascălu C; Bende B; Iliescu C; Carliuc V; Meitert T; Pencu E; Ciudin L; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):291-8. PubMed ID: 6400302
    [No Abstract]   [Full Text] [Related]  

  • 12. Septic shock associated with Shigella flexneri dysentery.
    Beigelman A; Leibovitz E; Sofer S
    Scand J Infect Dis; 2002; 34(9):692-3. PubMed ID: 12374365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment of dysentery patients with streptomycin-dependent vaccine in comparison with other methods of treatment].
    Iushchuk ND; Kichik EI; Sergeev VV; Godovannyĭ BA; Tumanov FA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Nov; (11):90-4. PubMed ID: 339618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The isolation of Shigella flexneri from blood cultures in acute shigellosis.
    CORDLE F; BOLTJES BH
    J S C Med Assoc; 1963 Aug; 59():278-9. PubMed ID: 14023004
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current problems of dysentery].
    Pokrovskiĭ VI
    Sov Med; 1978 May; (5):7-12. PubMed ID: 354019
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antidysenteric vaccination. XIV. Immunizing action on the guinea pig conjunctiva of various toxic extracts of pathogenic Shigella flexneri 2a TI, as compared with that of live cultures of two non-pathogenic strains of Shigella flexneri 2a].
    Istrati M; Istrati G
    Arch Roum Pathol Exp Microbiol; 1966 Mar; 25(1):55-64. PubMed ID: 5973711
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic effectiveness of nevigramon in the complex treatment of acute dysentery].
    Gebesh VV; Koval'chuk VK; Ianushevskaia RI; Sofienko NIa; Lysak LI
    Vrach Delo; 1980 May; (5):110-3. PubMed ID: 6994350
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and treatment characteristics of acute dysentery caused by Shigella boydii and newcastle].
    Mel'nik GV
    Vrach Delo; 1984 Aug; (8):114-7. PubMed ID: 6390958
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dispensary treatment of convalescents following acute dysentery].
    Tarasov VI; Voloshin AA
    Voen Med Zh; 1974 May; 5(0):46-8. PubMed ID: 4599744
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differential diagnosis of acute enterocolitis and acute dysentery].
    Sviridov LP
    Voen Med Zh; 1972 May; 5():50. PubMed ID: 4576192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.